PROVIDER PROFILE · NPI 1003824442

Jeffrey LoomerMD

PRACTICEARIZONA ARTHRITIS & RHEUMATOLOGY ASSOCIATES P CSee all providers at this practice →

RheumatologyTucson, AZI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

3,794

Unique beneficiaries

—

Total services

140,851

Distinct HCPCS

Medicare payment

$1.7M

Peer benchmark

Total Medicare services vs. 71 Rheumatology providers in AZ — above median (cohort median 9,320).

PRESCRIBING · PART D · 2024

Total Rx claims

2,396

Beneficiaries

—

Total drug cost

$2.9M

Distinct drugs

Brand share

30.8%

Top prescribed drugs

Prednisone424 claims

Methotrexate Sodium311 claims

Hydroxychloroquine Sulfate256 claims

Adalimumab164 claims

Gabapentin144 claims

QUALITY · MIPS · 2024

Final MIPS score

99.2

Quality

0.0

Cost

47.8

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

1.02%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

123

By payment type

Food and Beverage$3K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 031301

Hospital

REFERRAL NETWORK

Where Jeffrey Loomer's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ	25	78
Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ	15	38

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history